pelabresib
Generic: CPI-0610·Code: CPI-0610
pelabresib: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| CONSTELLATION PHARMACEUTICALS INC (CNST) | Phase 1 |
Clinical Trials (1)
A Phase 1, 2-Part Study to Evaluate the Effect of Food on Pharmacokinetics of Pelabresib (CPI-0610) and the Effect of Pelabresib on QTc in Patients With Advanced Malignancies
Frequently asked questions
Who is developing pelabresib?
pelabresib is being developed by CONSTELLATION PHARMACEUTICALS INC.
How many clinical trials involve pelabresib?
BioSniper tracks 1 clinical trial involving pelabresib.
Get deeper analysis on pelabresib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis